On behalf of a major investment management firm, we conducted a privileged independent investigation into whistleblower allegations of investor harm due to cell formula errors in a valuation model, as well as subsequent allegations of retaliation. Presented findings to the board of directors and the Securities and Exchange Commission. The SEC subsequently determined not to recommend an enforcement action by the Commission against the firm.
SEC and PCAOB Enforcement: 2023 accounting and audit highlights
Both the US Securities and Exchange Commission (SEC) and the US Public Company Accounting Oversight Board (PCAOB) reported increased enforcement activity in...